KEGG: mmu:230752
UniGene: Mm.41569
Recombinant Mouse Protein FAM176B (Fam176b) is a full-length protein corresponding to amino acids 1-164 of the native mouse Fam176b protein (Q8K2Y3). It is typically produced with an N-terminal His tag and expressed in E. coli expression systems to enable laboratory research applications . This recombinant version allows researchers to study the protein's functions in controlled experimental settings where the native protein might be difficult to isolate in sufficient quantities or purity.
Recombinant Mouse FAM176B is a relatively small protein consisting of 164 amino acids with the addition of an N-terminal histidine tag for purification purposes. The protein's molecular structure features characteristic domains that mediate its biological functions, though specific structural details are still being investigated by researchers. When expressed in E. coli, the protein maintains its primary sequence integrity while potentially lacking some post-translational modifications present in mammalian-expressed versions .
Unlike other recombinant mouse proteins such as B7-H2 (which is involved in T cell co-stimulation) or Fibulin-7 (which interacts with extracellular molecules like Fibronectin) , FAM176B has distinct biological functions. While proteins like BAFF are expressed in yeast systems to ensure proper folding and post-translational modifications , FAM176B is typically expressed in bacterial systems, which can impact its structural characteristics and experimental applications compared to these other proteins.
| Expression System | Advantages | Limitations | Best Used For |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid production | Limited post-translational modifications, potential improper folding | Structural studies, antibody production |
| Pichia pastoris | Better protein folding, some post-translational modifications | Lower yield than E. coli, longer production time | Functional assays requiring proper folding |
| Mammalian cells | Native-like post-translational modifications, proper folding | Expensive, low yield, complex protocols | Signaling studies, in vivo applications |
The choice of expression system should align with specific experimental requirements and the intended applications of the protein.
For His-tagged Recombinant Mouse FAM176B, immobilized metal affinity chromatography (IMAC) represents the primary purification method . For optimal purity, researchers should implement a multi-step purification strategy:
Initial capture using Ni-NTA or cobalt-based resins exploiting the His-tag affinity
Secondary purification using size exclusion chromatography to separate monomeric protein from aggregates
Optional ion exchange chromatography step if higher purity is required
Quality control assessment using SDS-PAGE and Western blotting to confirm purity and integrity
This approach typically yields protein with >95% purity suitable for most research applications.
Based on protocols for similar recombinant proteins, Recombinant Mouse FAM176B should be stored under the following conditions to maintain stability and activity:
Store lyophilized protein at -20°C to -80°C for long-term storage
After reconstitution, aliquot to minimize freeze-thaw cycles
Use a manual defrost freezer and avoid repeated freeze-thaw cycles, which can compromise protein integrity
For short-term use (1-2 weeks), store reconstituted protein at 4°C
Add carrier proteins such as BSA (0.1-1%) to enhance stability in solution for dilute preparations
These storage protocols help maintain protein activity and structural integrity for extended periods.
For proper reconstitution of lyophilized Recombinant Mouse FAM176B:
Allow the protein vial to reach room temperature before opening
Reconstitute in sterile PBS to a concentration of approximately 500 μg/mL
Gently mix by rotating or inverting the vial until completely dissolved; avoid vigorous shaking or vortexing
For certain applications, consider adding a carrier protein such as 0.1% BSA if the protein will be diluted below 100 μg/mL
Allow the protein to sit for 15-30 minutes after reconstitution before use to ensure complete solubilization
Proper reconstitution ensures maintenance of protein structure and biological activity for experimental applications.
Recombinant Mouse FAM176B can be utilized in various experimental applications similar to other recombinant proteins:
As a standard in quantitative ELISA assays for measuring endogenous protein levels
In Western blot analysis as a positive control for antibody validation
For in vitro binding studies to identify interaction partners
In cell culture experiments to assess biological activities and cellular responses
For antibody production as an immunogen
In structural studies including crystallography or NMR spectroscopy
Each application requires specific consideration of protein concentration, buffer conditions, and experimental design parameters.
When implementing cell-based assays with Recombinant Mouse FAM176B:
Determine appropriate concentration ranges through dose-response experiments (typically 0.1-10 μg/mL based on similar proteins)
Include proper controls, including untreated cells and cells treated with irrelevant proteins of similar size
Consider pre-conditioning the protein in culture media containing serum for 30 minutes before cell treatment
Evaluate multiple timepoints to capture both early and late cellular responses
Use complementary assays (e.g., Western blotting, flow cytometry, immunofluorescence) to validate observations
These methodological considerations enhance the reliability and reproducibility of cell-based experiments.
If experiencing solubility issues with Recombinant Mouse FAM176B:
Adjust the reconstitution buffer pH (try ranges between pH 6.8-8.0)
Add low concentrations of non-ionic detergents (0.01-0.05% Tween-20) to prevent aggregation
Increase the ionic strength of the buffer through addition of NaCl (up to 150-300 mM)
Consider reconstituting at lower concentrations initially (100-200 μg/mL) before diluting to working concentration
Implement gentle filtration through low protein-binding 0.22 μm filters if particulates persist
For severe aggregation, consider adding mild denaturants like 1-2 M urea followed by gradual dialysis
These approaches can significantly improve protein solubility while maintaining structural integrity.
To improve reproducibility with Recombinant Mouse FAM176B experiments:
Implement stringent quality control measures for each protein lot using SDS-PAGE and activity assays
Standardize preparation protocols, including consistent reconstitution procedures
Create a detailed data table recording experimental parameters as shown below:
| Experiment Date | Protein Lot | Reconstitution Buffer | Storage Duration | Experimental Outcome | Notes |
|---|---|---|---|---|---|
Minimize freeze-thaw cycles by preparing single-use aliquots
Validate protein activity using established functional assays before key experiments
Control for environmental variables like temperature and humidity during sensitive assays
This systematic approach facilitates identification of variables contributing to inconsistent results.
The N-terminal His-tag present on Recombinant Mouse FAM176B can potentially impact:
Protein folding dynamics, especially if the N-terminus is involved in structural elements
Binding interactions with partner proteins or receptors if the tag introduces steric hindrance
Enzymatic activity if the protein possesses catalytic functions sensitive to N-terminal modifications
Crystallization behavior during structural studies
For critical applications where the tag might interfere, researchers should consider:
Using tag-removal strategies via engineered protease sites
Comparing results with alternatively tagged versions (C-terminal or internal tags)
Validating findings with native (untagged) protein if available
Implementing computational modeling to predict potential tag interference
To elucidate structure-function relationships of Recombinant Mouse FAM176B, consider these advanced techniques:
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map protein dynamics and ligand-binding interfaces
Surface plasmon resonance (SPR) or bio-layer interferometry (BLI) for quantitative binding kinetics
Circular dichroism (CD) spectroscopy to assess secondary structure composition
Thermal shift assays to evaluate stability under various buffer conditions
Small-angle X-ray scattering (SAXS) for solution-state structural information
Cross-linking mass spectrometry to identify interaction domains
These methods provide complementary insights into protein behavior that can inform experimental design and interpretation.
Emerging research with Recombinant Mouse FAM176B is focusing on several promising directions:
Development of structure-guided mutations to probe functional domains
Investigation of tissue-specific expression patterns and their correlation with physiological functions
Exploration of potential roles in signaling pathways through proteomic approaches
Comparative studies with human FAM176B to establish translational relevance
Integration of computational and experimental approaches to predict binding partners and functional networks
These research trajectories will expand our understanding of FAM176B biological significance and potential applications in both basic and translational research contexts.
Researchers can advance the field by:
Publishing standardized protocols for expression, purification, and functional characterization
Depositing structural data in public databases like the Protein Data Bank
Developing and sharing new antibodies or detection reagents specific to FAM176B
Creating knockout or conditional mouse models to study in vivo functions
Establishing collaborations across disciplines to investigate the protein from multiple perspectives
Implementing CRISPR-Cas9 approaches for endogenous tagging and live-cell imaging